Inc.com Women’s Summit This seven-day conference is designed to fully immerse you into the Lean Startup methodology popularized by Eric Ries in his book, The Lean Startup. This event is for you if you’re interested in hacking business models, mastering the lean startup process, and learning from the companies that [..]
Novel Ultrathin Semiconductor Materials By Stanford Engineers By: Andrew Myers | Stanford News The next generation of feature-filled and energy-efficient electronics will require computer chips just a few atoms thick. For all its positive attributes, trusty silicon can’t take us to these ultrathin extremes. Now, electrical engineers at Stanford have [..]
U.S. FDA Approved Pfizer’s BESPONSA® : New Treatment For Relapsed or Refractory Acute Lymphoblastic Leukemia By: Pfizer News Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has approved BESPONSA® (inotuzumab ozogamicin) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).1BESPONSA was reviewed [..]
INC. 5000 Celebrate your growing success at the Inc. 5000 Conference & Gala. Be among the most successful entrepreneurs for three days of power networking, breakthrough insights, and pure fun. 00
TechCrunch Disrupt SF 2017 Startups Start Here TechCrunch Disrupt is the world’s leading authority in debuting revolutionary startups, introducing game-changing technologies and discussing what’s top of mind for the tech industry’s key innovators. Disrupt gathers the best and brightest entrepreneurs, investors, hackers, and tech fans for on-stage interviews, the Startup [..]
AbbVie Receives FDA Approval of MAVYRET™ for the Treatment of Chronic Hepatitis C By: Abbvie News AbbVie, a global biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved MAVYRET™ (glecaprevir/pibrentasvir), a once-daily, ribavirin-free treatment for adults with chronic hepatitis C virus (HCV) infection across all major genotypes [..]
New Biomarkers Associated With Chronic Fatigue Syndrome Severity By: Bruce Goldman | Stanford News Researchers at the Stanford University School of Medicine have linked chronic fatigue syndrome to variations in 17 immune-system signaling proteins, or cytokines, whose concentrations in the blood correlate with the disease’s severity. The findings provide evidence that inflammation [..]
Fast, Noninvasive Technique For Probing Cells May Reveal Disease By: Jennifer Chu | MIT News Office The stiffness or elasticity of a cell can reveal much about whether the cell is healthy or diseased. Cancer cells, for instance, are known to be softer than normal, while asthma-affected cells can be [..]
Copyright © 2024 | WordPress Theme by MH Themes